Skip to content

Obesity Tech

Health First

  • Your Health Checker
    • Early Childhood Obesity Calculator
    • Gut Health Score Calculator
    • BMI Calculator Women
    • Obesity Risk Assessment Tool
    • BMI Calculator
    • Waist-to-Hip Ratio Calculator
    • Calorie Deficit Calculator
    • Stroke Risk Checker
    • Your Body, Your Healthy Weight Range
    • Mindful Eating Score Calculator 
    • Sedentary Behavior Impact Calculator
    • What Is Body Roundness Index (BRI)?
    • Visceral Fat Calculator
  • Research Insights
  • Advisory
  • Tech
  • Story
    • 10 Ultra-Processed Foods to Avoid for Obesity Prevention
    • 10 Superfoods That Help You Lose Belly Fat Naturally
  • Metabolic Age Calculator

Tag: Semaglutide

Research Insights

Semaglutide Linked to Fewer Asthma Attacks: What the New Research Found

Semaglutide, the active ingredient in medicines such as Ozempic and Wegovy, may have an unexpected connection with respiratory health. New…

September 10, 2026September 10, 2026
Semaglutide Brand Names: Wegovy, Ozempic and Rybelsus Explained
Research Insights

Semaglutide Brand Names: Wegovy, Ozempic and Rybelsus Explained

Semaglutide is a prescription medicine that belongs to the GLP-1 receptor agonist class. It has become one of the most…

August 23, 2026August 23, 2026
Semaglutide in the ESSENCE Trial: A Breakthrough for Liver Disease Treatment?
Research Insights

Semaglutide in the ESSENCE Trial: A Breakthrough for Liver Disease Treatment?

Liver disease, especially metabolic dysfunction-associated steatohepatitis (MASH), has long been a silent threat, affecting millions of people globally. Often progressing…

May 28, 2025August 10, 2026
Weight-Loss Jabs Could Slash Cancer Risk by 50%: A “Transformational” Breakthrough
Research Insights

Weight-Loss Jabs Could Slash Cancer Risk by 50%: A “Transformational” Breakthrough

Key Findings at a Glance The Study: How Weight-Loss Drugs Stack Up Against Surgery A landmark Israeli study (presented at the European Congress…

May 12, 2025May 12, 2025
Tirzepatide vs. Semaglutide for Obesity: Which Weight-Loss Drug Works Better?
Research Insights

Tirzepatide vs. Semaglutide for Obesity: Which Weight-Loss Drug Works Better?

New SURMOUNT-5 Trial Results (2025) Key Takeaways ✅ Tirzepatide (Zepbound) led to significantly greater weight loss than semaglutide (Wegovy). Background: The…

May 12, 2025May 12, 2025
Frequent Asked Questions about Obesity
Research Insights

Frequent Asked Questions about Obesity

Obesity is one of the most misunderstood health crises of our time. Below, we tackle the most pressing questions—backed by…

May 10, 2025May 10, 2025
The Paradox of Obesity Drugs: How Opposite Approaches Both Lead to Weight Loss
Research Insights

The Paradox of Obesity Drugs: How Opposite Approaches Both Lead to Weight Loss

A Scientific Mystery Solved In a breakthrough that defies conventional logic, researchers have discovered that two completely opposite drug strategies—stimulating and blocking the same…

May 4, 2025May 4, 2025

Posts pagination

1 2 … 4 Next

Recent Posts

  • UK Obesity Rate: A Persistent Public Health Challenge
  • Semaglutide Linked to Fewer Asthma Attacks: What the New Research Found
  • GLP-1 Meal Ideas: Simple Foods for Weight Loss
  • TOFA: Experimental Obesity Drug Makes Mice Burn More Fat Without Eating Less
  • Semaglutide Brand Names: Wegovy, Ozempic and Rybelsus Explained

Archives

  • September 2026
  • August 2026
  • January 2026
  • September 2025
  • August 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025

Categories

  • Advisory
  • Research Insights
  • Story
  • Tech

Health Calculators

  • Your Health Checker
  • BMI Calculator
  • Contributor’s
  • Contact
  • Privacy Policy
  • Terms and Conditions

Copyright © 2026 Obesity Tech | Lite Blog by Ascendoor | Powered by WordPress.